Quantcast

Posts related to ‘IMRX’

Biotech Finance Daily (DNDN)(MRK)(DNA)(BRCX)

Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company's news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke disappointed the ...
Read Full Story »

Largest IPO Percentage Losses of 2007 (CHIP, DEEP, ZBB, BBND, MMPI, GLUU, IMRX, GSIT, XFML, PINN, LLNW)

247WallSt.com wanted to bring a best and worst in IPO's for 2007.  Many investors look for recent IPO's that have seen the shares hit hard since coming public.  Some of ...
Read Full Story »